Ruthenium Complex Induce Cell Death in G-415 Gallbladder Cancer Cells
- 13 August 2019
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 51 (2) , 571-578
Abstract
Purpose In this work, we present a recently developed ruthenium complex that shows anticancer activity in gallbladder cancer cells. Methods After the synthesis of the new ruthenium complexes, the antiproliferative, cytotoxicity, and apoptosis activities were evaluated in vitro by the triple assay ApoTox-Glo. Then, the transcription levels of genes related to apoptosis were evaluated by real-time PCR (q-PCR). Results The ruthenium complex, called Ru-UCN3, inhibits the proliferation of gallbladder cancer cells G-415 by means of apoptosis, which was demonstrated by the overexpression of the pro-apoptotic genes Puma, Diablo, and Caspasa-9 together with the repression of the anti-apoptotic genes Bcl-xL and Bcl-2. In addition, we found strong caspase 3/7 activity in the cells at 24 h of the Ru-UCN3 exposure, which was evaluated by the triple ApoTox-Glo assay. Conclusion The new ruthenium complexes evaluated had an inhibitory effect on G-415 cells. We think that Ru-UCN3 could be a promising anticancer agent, which should be explored with more in vitro and in vivo assays and probably with the chemical modulation of this molecule.Keywords
This publication has 27 references indexed in Scilit:
- Impact of low- and high-molecular-mass components of human serum on NAMI-A binding to transferrinJBIC Journal of Biological Inorganic Chemistry, 2015
- Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor CellsPLOS ONE, 2014
- Apoptosis and Molecular Targeting Therapy in CancerBioMed Research International, 2014
- Subcellular Localization and Transport Kinetics of Ruthenium Organometallic Anticancer Compounds in Living Cells: A Dose-Dependent Role for Amino Acid and Iron TransportersInorganic Chemistry, 2014
- Epidemiology of Gallbladder Disease: Cholelithiasis and CancerGut and Liver, 2012
- Induction of Cell Cycle Arrest and Apoptosis by Ruthenium Complex cis-(Dichloro)tetramineruthenium(III) Chloride in Human Lung Carcinoma Cells A549Biological Trace Element Research, 2011
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Current Management of Gallbladder CarcinomaThe Oncologist, 2010
- Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinomaAnnals of Oncology, 2005
- Protein‐binding Properties of two Antitumour Ru(III) Complexes toHuman Apotransferrin and ApolactoferrinMetal-Based Drugs, 1994